BrainStorm Presentation on New Biomarker Data ... (NASDAQ: BCLI, "the Company"), a leading ... Investor Contact. Investor FAQs. Investor FAQs. RSS Feeds. RSS ...
People also ask
What is the price target for BCLI?
Is NurOwn FDA approved?
Who is the CEO of Brainstorm Cell Therapeutics?
What is NurOwn?
BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, biotechnology company focused on the development of best-in-class autologous cellular ...
Get the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock news and headlines to help you in your trading and investing decisions.
Missing: investor relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
View the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Missing: relations | Show results with:relations
Find the latest Brainstorm Cell Therapeutics Inc. (BCLI) stock quote, history, news and other vital information to help you with your stock trading and ...
Missing: relations | Show results with:relations
... Annual Report on Form 10-K are split-adjusted. The Company's Common Stock trades on the Nasdaq Capital Market under the ticker symbol “BCLI.” Company ...